Cellanome
PrivateLast Round
Series B
Jun 22, 2026
Est. Valuation
$525M
Total Funding Raised
$217.75M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Cellanome is a biotechnology company that develops an integrated multi-omics platform for high-resolution, large-scale biological measurement and live-cell analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting, Hardware + Subscription, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellanome Comparables
Compare Cellanome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mission Bio | 79% | |
| Singleron Biotechnologies | 77% | |
| Neomend | 75% | |
Cellanome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 22, 2026 | ||||
| Series B | Jan 29, 2024 | ||||
| Series A | Mar 21, 2023 | ||||
| Seed | Oct 5, 2021 | ||||
| Series A | Jul 1, 2021 |
Cellanome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Angel | Series B, Seed, Series A |
| Khosla Ventures | Series A |
| RONA Holdings | Series A, Seed |
| Wing Venture Capital | Series B, Seed, Series A |
| DFJ Growth | Seed, Series A, Series B |
| Premji Invest | Series B, Seed, Series A |
| 8VC | Series B, Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Raised $76M in Series B funding.
- Apr 1, 2026
Hiring for Director of Product Management for the Cellanome R3200 platform.
Cellanome Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cellanome's valuation, stock price, and market status.